Biomarkers in head and neck squamous cell carcinoma (HNSCC)-An update

Biomarkers in head and neck squamous cell carcinoma (HNSCC)-An update

Saved in:

Bibliographic Details
Main Authors:	Thirumalaikumaran R, Vandhana V, Meenaloshini G, Sri Vaishnavi V
Format:	Article
Language:	English
Published:	Elsevier 2024-09-01
Series:	Oral Oncology Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2772906024004576
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Next-generation sequencing (NGS) for the personalized treatment of head and neck squamous cell carcinoma (HNSCC)
by: Prasad Monisha, et al.
Published: (2024-06-01)

Comment on “TGM3 - A novel biomarker as a potential diagnostic target for head and neck squamous cell carcinoma (HNSCC)”
by: Muthupandian Saravanan
Published: (2024-09-01)

Prosaposin – A plausible biomarker in head and neck squamous cell carcinoma
by: Avradeep Datta, et al.
Published: (2024-03-01)

Cutaneous Squamous Cell Carcinoma of the Head and Neck
by: Vivek V. Gurudutt, et al.
Published: (2011-01-01)

The volatilome – investigation of volatile organic metabolites (VOM) as potential tumor markers in patients with head and neck squamous cell carcinoma (HNSCC)
by: Philipp Opitz, et al.
Published: (2018-07-01)

Head and Neck Squamous Cell Carcinoma: NT5E Could Be a Prognostic Biomarker
by: Yaoting Zhang, et al.
Published: (2022-01-01)

Outcomes of Recurrent Head and Neck Cutaneous Squamous Cell Carcinoma
by: Nichole R. Dean, et al.
Published: (2011-01-01)

Targeting Akt signaling in head and neck squamous cell carcinoma
by: Madhan Krishnan, et al.
Published: (2024-06-01)

Pathological margins and advanced cutaneous squamous cell carcinoma of the head and neck
by: T. J. Phillips, et al.
Published: (2019-10-01)

Kruppel-family zinc finger proteins as emerging epigenetic biomarkers in head and neck squamous cell carcinoma
by: Patrick Pearson, et al.
Published: (2023-05-01)

Analytical performance of OncoPrism-HNSCC, an RNA-based assay to inform immune checkpoint inhibitor treatment decisions for recurrent/metastatic head and neck squamous cell carcinoma
by: Jeffrey Hiken, et al.
Published: (2025-01-01)

Depth-dependent PD-L1 sampling of head and neck squamous cell carcinoma (HNSCC) – implications for PD-1/PD-L1 checkpoint inhibitor immunotherapy
by: Madhusudan Roy, et al.
Published: (2024-03-01)

Microbial signatures in head and neck squamous cell carcinoma: an in silico study
by: Loganathan KAVITHA, et al.
Published: (2025-02-01)

Immunosuppression and Outcomes in Patients with Cutaneous Squamous Cell Carcinoma of the Head and Neck
by: Doriana Iancu, et al.
Published: (2025-01-01)

Recent advances of photodiagnosis and treatment for head and neck squamous cell carcinoma
by: Yining Zhang, et al.
Published: (2025-02-01)

Letter to the editor, “Depth-dependent PD-L1 sampling of head and neck squamous cell carcinoma (HNSCC) – Implications for PD-1/PD-L1 checkpoint inhibitor immunotherapy.”
by: Geetha Shanmugam
Published: (2024-09-01)

Evaluating H2BC9 as a potential diagnostic and prognostic biomarker in head and neck squamous cell carcinoma
by: Lanhua Wu, et al.
Published: (2025-01-01)

Comprehensive analyses reveal the promising value of gasdermins as prognostic biomarkers and immunotherapeutic targets in head and neck squamous cell carcinoma
by: Huageng Huang, et al.
Published: (2025-01-01)

Cetuximab Plus Methotrexate in Recurrent and/or Metastatic Head-and-Neck Squamous Cell Carcinoma
by: Wen-Chen Tang, et al.
Published: (2023-07-01)

Expression and prognosis of cellular senescence genes in head and neck squamous cell carcinoma
by: Chen Feng, et al.
Published: (2025-01-01)

Disulfidptosis-related gene SLC3A2: a novel prognostic biomarker in nasopharyngeal carcinoma and head and neck squamous cell carcinoma
by: Xinyi Zhang, et al.
Published: (2025-01-01)

A panel of cancer testis antigens in squamous cell carcinoma of the lung, head and neck, and esophagus: implication for biomarkers and therapeutic targets
by: Lin Li, et al.
Published: (2025-01-01)

Prognostic Significance and Therapeutic Potential of SERPINE1 in Head and Neck Squamous Cell Carcinoma
by: Changyu Zhu, et al.
Published: (2025-01-01)

Prognostic factors of head and neck cutaneous squamous cell carcinoma: a systematic review
by: Joshua Lubov, et al.
Published: (2021-09-01)

Exploring the influence of Interleukin-1 ligand expression in head and neck squamous cell carcinoma
by: Madhan Krishnan, et al.
Published: (2024-06-01)

Using proton therapy to treat head and neck cancer and oral squamous cell carcinoma
by: Mohamed Imath, et al.
Published: (2024-06-01)

Cancer stem cells in head and neck squamous cell carcinoma and its associated markers: A review
by: Lavanya Mallika, et al.
Published: (2024-04-01)

An Investigation of the Prognostic Role of Genes Related to Lipid Metabolism in Head and Neck Squamous Cell Carcinoma
by: Ling Qian, et al.
Published: (2023-01-01)

A Metabolic Gene Signature to Predict Overall Survival in Head and Neck Squamous Cell Carcinoma
by: Zeng-Hong Wu, et al.
Published: (2020-01-01)

Targeting ferroptosis for improved radiotherapy outcomes in HPV‐negative head and neck squamous cell carcinoma
by: Joo Kyung Noh, et al.
Published: (2025-02-01)

Study of the association of the known prognostic variables with EGFR expression in head and neck squamous cell carcinomas
by: Toyaja Jadhav, et al.
Published: (2023-07-01)

Identification of novel therapeutic targets for head and neck squamous cell carcinoma through bioinformatics analysis
by: Eun-jeong Jeong, et al.
Published: (2024-12-01)

Understanding the tumor microenvironment for personalized immunotherapy in early-onset head and neck squamous cell carcinoma
by: Yidan Shan, et al.
Published: (2025-01-01)

Metagenomic Profiling of Oral Microbiome Dynamics During Chemoradiotherapy in Head and Neck Squamous Cell Carcinoma Patients
by: Dominique A. Torozan, et al.
Published: (2025-01-01)

Identification of the Immune Cell Infiltration Landscape in Head and Neck Squamous Cell Carcinoma (HNSC) for the Exploration of Immunotherapy and Prognosis
by: Chunli Huang, et al.
Published: (2022-01-01)

Phase I study of intratumoral administration of CV8102 in patients with advanced melanoma, squamous cell carcinoma of the skin, squamous cell carcinoma of the head and neck, or adenoid cystic carcinoma
by: Lucie Heinzerling, et al.
Published: (2025-02-01)

Neoadjuvant chemoimmunotherapy for locally advanced squamous cell carcinoma of the head and neck: Systematic review and meta-analysis
by: Xiayi Zhu, et al.
Published: (2025-02-01)

Response to induction chemotherapy as a prognostic indicator in locally advanced head and neck squamous cell carcinoma
by: Francesca Huwyler, et al.
Published: (2024-12-01)

Telomerase Activity Levels in the Surgical Margin and Tumour Distant Tissue of the Squamous Cell Carcinoma of the Head-And-Neck
by: Eva‐Maria Fabricius, et al.
Published: (2002-01-01)

Clinicopathological Significance of FOXO4 Expression and Correlation with Prx1 in Head and Neck Squamous Cell Carcinoma
by: Yunping Lu, et al.
Published: (2021-01-01)